1.94 USD
-0.26 (-11.82%)
1.9601 USD
+0.02 (+1.04%)
ChartMill assigns a Buy % Consensus number of 84% to PALI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.9. This target is 513.4% above the current price.
PALI was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PALI.
In the previous month the buy percentage consensus was at a similar level.
PALI was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-13 | Brookline Capital | Maintains | Buy -> Buy |
| 2024-11-20 | Brookline Capital | Initiate | Buy |
| 2024-11-13 | Maxim Group | Maintains | Buy -> Buy |
| 2024-05-01 | Maxim Group | Reiterate | Buy -> Buy |
| 2024-04-16 | Maxim Group | Maintains | Buy -> Buy |
| 2023-11-17 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-05-16 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-03-30 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-08-19 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-02-02 | Ladenburg Thalmann | Initiate | Buy |
| 2021-08-31 | Maxim Group | Initiate | Buy |
PALISADE BIO INC / PALI FAQ
What do analysts expect the price target to be for PALISADE BIO INC (PALI)?
9 analysts have analysed PALI and the average price target is 11.9 USD. This implies a price increase of 513.4% is expected in the next year compared to the current price of 1.94.
What is the consensus rating for PALI stock?
The consensus rating for PALISADE BIO INC (PALI) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.